Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/26947
Title: Sex differences in causes of death after stroke: Evidence from a national, prospective registry.
Authors: Anderson C.S.;Cadilhac D.A.;Kilkenny M.F.;Castley H.C.;Grimley R.;Lannin N.A.;Thrift A.G. ;Kim J.;Phan H.T.;Gall S.;Blizzard C.L.
Institution: (Phan, Gall, Blizzard) Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (Phan) Department of Public Health Management, Pham Ngoc Thach University of Medicine, Ho Chi Minh, Vietnam (Phan, Thrift, Kim, Grimley, Kilkenny, Cadilhac) Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia (Lannin) Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia (Lannin) Alfred Health, Melbourne, Australia (Anderson) Faculty of Medicine, The George Institute for Global Health, The University of New South Wales, Sydney, Australia (Kim, Kilkenny, Cadilhac) Stroke Theme, The Florey Institute of Neuroscience and Mental Health, Heidelberg, VIC, Australia (Grimley) Sunshine Coast Clinical School, University of Queensland, Birtinya, Australia (Castley) Neurology Department, Royal Hobart Hospital, Hobart, Australia
Issue Date: 18-Mar-2021
Copyright year: 2021
Publisher: Mary Ann Liebert Inc.
Place of publication: United States
Publication information: Journal of Women's Health. 30 (3) (pp 314-323), 2021. Date of Publication: March 2021.
Journal: Journal of Women's Health
Abstract: Background: We examined sex differences in cause of death and cause-specific excess mortality after stroke. Material(s) and Method(s): First-ever strokes (2010-2013; 35 hospitals) participating in the Australian Stroke Clinical Registry were linked to national death registrations and other administrative datasets. One-year cause-specific mortality was categorized as stroke, ischemic heart disease, other cardiovascular disease (CVD; e.g., hypertension), cancer, and other. Specific hazard ratios (sHRs) of death for women compared to men were estimated using competing risk models, with adjustment for factors differing by sex (e.g., age and stroke severity). Age- and sex-specific mortality rates expected in the general population were derived from national data. Standardized mortality ratios (SMRs; observed/expected deaths) were estimated for cause-specific mortality by sex after age standardization. Result(s): Among 9,441 cases (46% women), women were 7 years older than men, had more severe strokes, and received similar patterns of suboptimal secondary prevention medications at discharge. Women had greater mortality associated with stroke (sHRunadjusted 1.65) and other CVD (sHRunadjusted 1.65), which was related to age and stroke severity rather than other factors. Compared to population norms, those surviving to 30 days had eight-fold increased mortality from stroke (primary/recurrent) events irrespective of sex (SMRage-standardised women 8.8; men 8.3). Excess mortality from other CVD was greater in women (SMRage-standardised 3.6 vs. men 2.8; p = 0.026). Conclusion(s): Cause-specific mortality after first-ever stroke differs by sex. The greater death rate attributed to stroke/other CVD in women was mostly explained by age and stroke severity. Greater implementation of secondary stroke prevention is relevant to both sexes.© Copyright 2021, Mary Ann Liebert, Inc., publishers 2021.
DOI: http://monash.idm.oclc.org/login?url=
http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1089/jwh.2020.8391
PubMed URL: 33227218 [http://www.ncbi.nlm.nih.gov/pubmed/?term=33227218]
ISSN: 1540-9996
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/26947
Type: Article
Subjects: major clinical study
male
malignant neoplasm
*mortality
multicenter study
outcome assessment
priority journal
prospective study
Queensland
risk factor
secondary prevention
*sex difference
skin cancer
urinary tract cancer
antihypertensive agent/dt [Drug Therapy]
fibrinolytic agent/dt [Drug Therapy]
fibrinolytic agent/iv [Intravenous Drug Administration]
hypertension/dt [Drug Therapy]
adult
age
aged
article
atrial fibrillation
cardiovascular disease
*cause of death
*cerebrovascular accident/dt [Drug Therapy]
*cerebrovascular accident/ep [Epidemiology]
Charlson Comorbidity Index
controlled study
dementia
diabetes mellitus
disease severity
emergency care
female
fibrinolytic therapy
heart failure
hospital discharge
human
hyperlipidemia
International Classification of Diseases
ischemic heart disease
dementia
diabetes mellitus
disease severity
age
female
fibrinolytic therapy
heart failure
hospital discharge
human
hyperlipidemia
hypertension / drug therapy
International Classification of Diseases
ischemic heart disease
major clinical study
male
malignant neoplasm
*mortality
multicenter study
outcome assessment
priority journal
prospective study
Queensland
risk factor
secondary prevention
*sex difference
skin cancer
adult
emergency care
aged
Article
atrial fibrillation
cardiovascular disease
*cause of death
*cerebrovascular accident / *drug therapy / *epidemiology
Charlson Comorbidity Index
controlled study
urinary tract cancer
Appears in Collections:Articles

Show full item record

Page view(s)

24
checked on Aug 18, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.